Skip to main content
. 2020 May 29;10:709. doi: 10.3389/fonc.2020.00709

Table 5.

Number of recurrence (N) following treatment of isPM and number of affected organs (cases at risk).

Recurrence organ sites N %
All sites 116 (265) 43.7
One organ metastasis 79 (116) 68.1
    Pancreas 17 21.5
    Non-pancreas 62 78.5
Multiple organs metastases 37 (116) 31.9
    2-organs 19
    3-organs 6
    Multiple 12